China Universal Asset Management Co., Ltd. Cabaletta Bio, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,206 shares of CABA stock, worth $57,852. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,206
Previous 8,206
-0.0%
Holding current value
$57,852
Previous $140,000
0.71%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CABA
# of Institutions
168Shares Held
48.8MCall Options Held
300KPut Options Held
1.31M-
Black Rock Inc. New York, NY4.06MShares$28.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$26.4 Million0.0% of portfolio
-
Jennison Associates LLC3.42MShares$24.1 Million0.04% of portfolio
-
Fred Alger Management, LLC New York, NY3.11MShares$21.9 Million0.27% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$21.4 Million0.1% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $205M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...